694 Spam-Free Article(s) Found
Sort:
Like
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Thursday’s Close
LLY Eli Lilly and Company $105.71 $113.53B N/A
Article Searches
Incyte (INCY) Beats on Q3 Earnings & Sales, Ups Jakafi View http://www.zacks.com/stock/news/590995/incyte-incy-beats-on-q3-earnings-sales-ups-jakafi-view?cid=CS-ZC-FT-analyst_blog|earnings_article-590995 Oct 29, 2019 - Incyte (INCY) reports better-than-expected results for the third quarter of 2019, owing to strong Jakafi sales.
Value Biotech ETFs & Stocks to Buy Now http://www.zacks.com/stock/news/602866/value-biotech-etfs-stocks-to-buy-now?cid=CS-ZC-FT-etf_news_and_commentary-602866 Nov 04, 2019 - Biotech valuation looks attractive amid a volley of good news. Investors can tap these stocks and ETFs.
What's in the Cards for Teva (TEVA) This Earnings Season? http://www.zacks.com/stock/news/602734/whats-in-the-cards-for-teva-teva-this-earnings-season?cid=CS-ZC-FT-analyst_blog|earnings_preview-602734 Nov 04, 2019 - Pricing erosion in U.S. generics market and rapid erosion in sales of Copaxone are likely to have hurt Teva's (TEVA) Q3 sales
FDA Panel Votes Against Lilly's Jardiance for Type I Diabetes http://www.zacks.com/stock/news/619673/fda-panel-votes-against-lillys-jardiance-for-type-i-diabetes?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-619673 Nov 14, 2019 - Eli Lilly (LLY) gets an unfavorable FDA panel vote to expand the label of its type II diabetes medicine Jardiance (2.5 mg) for type I diabetes.
Alkermes Submits NDA to FDA for Schizophrenia & Bipolar I Drug http://www.zacks.com/stock/news/629205/alkermes-submits-nda-to-fda-for-schizophrenia-bipolar-i-drug?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-629205 Nov 20, 2019 - Alkermes (ALKS) submits NDA to the FDA seeking approval of ALKS 3831 for the treatment of schizophrenia and bipolar I disorder.
Pharma Stock Roundup: MRK, SNY to Buy Cancer Firms, LLY Starts New Lung Cancer Study http://www.zacks.com/stock/news/668756/pharma-stock-roundup-mrk-sny-to-buy-cancer-firms-lly-starts-new-lung-cancer-study?cid=CS-ZC-FT-analyst_blog|stock_roundup-668756 Dec 13, 2019 - This week two deals grab headlines in the pharma space. Merck (MRK) offers to buy ArQule for $2.7 billion while Sanofi (SNY) signs a definitive deal to purchase Synthorx for $2.5 billion
Lilly's Cyramza Gets CHMP Recommendation for First-Line NSCLC http://www.zacks.com/stock/news/673027/lillys-cyramza-gets-chmp-recommendation-for-first-line-nsclc?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-673027 Dec 16, 2019 - Lilly's (LLY) regulatory application seeking approval for cancer drug, Cyramza, in combination with erlotinib for treating EGFR-mutated NSCLC in first-line setting gets positive CHMP opinion for approval in EU.
Lilly's Stock Up on Upbeat Sales & Profit Outlook for 2020 http://www.zacks.com/stock/news/676513/lillys-stock-up-on-upbeat-sales-profit-outlook-for-2020?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-676513 Dec 18, 2019 - Eli Lilly's (LLY) stock up on Tuesday after it provides an upbeat financial guidance for the next year.
Top Stock Reports for Johnson & Johnson, Eli Lilly & PNC Financial http://www.zacks.com/research-daily/676738/top-stock-reports-for-johnson-johnson-eli-lilly-pnc-financial?cid=CS-ZC-FT-research_daily-676738 Dec 18, 2019 - Top Stock Reports for Johnson & Johnson, Eli Lilly & PNC Financial
The Zacks Analyst Blog Highlights: Johnson & Johnson, Eli Lilly, PNC Financial, EOG Resources and Archer-Daniels-Midland http://www.zacks.com/stock/news/678361/the-zacks-analyst-blog-highlights-johnson-johnson-eli-lilly-pnc-financial-eog-resources-and-archer-daniels-midland?cid=CS-ZC-FT-press_releases-678361 Dec 19, 2019 - The Zacks Analyst Blog Highlights: Johnson & Johnson, Eli Lilly, PNC Financial, EOG Resources and Archer-Daniels-Midland

Pages: 1...6364656667686970

<<<Page 68>